Old North Strategies is a government affairs (lobbying) firm representing Exela Pharma Sciences, a biopharmaceutical company. The filings show they lobby on manufacturing-related issues and health issues, including advanced biotechnology manufacturing policies and reducing aluminum toxicity in medicines. Their reports total $160,000 across four filings, most recently in January 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOSEPH ROBERT MURRAY
The latest disclosures for this client.
FIRST PRINCIPLES STRATEGIES, LLC
Q1FIRST PRINCIPLES STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FIRST PRINCIPLES STRATEGIES, LLC
FIRST PRINCIPLES STRATEGIES, LLC
Q3FIRST PRINCIPLES STRATEGIES, LLC
Q2FIRST PRINCIPLES STRATEGIES, LLC
Q1